Overview
Availability
- Dr Aakanksha Dixit is:
- Available for supervision
Works
Search Professor Aakanksha Dixit’s works on UQ eSpace
2023
Journal Article
An appraisal of emerging therapeutic targets for multiple sclerosis derived from current preclinical models
Dixit, Aakanksha, Savage, Hannah S. and Greer, Judith M. (2023). An appraisal of emerging therapeutic targets for multiple sclerosis derived from current preclinical models. Expert Opinion on Therapeutic Targets, 27 (7), 553-574. doi: 10.1080/14728222.2023.2236301
2022
Other Outputs
Investigating the mechanism of action of a novel therapeutic derived from parasitic worms in animal models of multiple sclerosis
Dixit, Aakanksha (2022). Investigating the mechanism of action of a novel therapeutic derived from parasitic worms in animal models of multiple sclerosis. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/4f7dd64
2017
Journal Article
Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms
Dixit, Aakanksha, Tanaka, Akane, Greer, Judith M and Donnelly, Sheila (2017). Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms. International Journal of Molecular Sciences, 18 (10) 2141, 1-17. doi: 10.3390/ijms18102141
2017
Conference Publication
Using a parasite derived peptide to prevent immune-mediated demyelination
Donnelly, Sheila, Greer, Judith and Dixit, Aakanksha (2017). Using a parasite derived peptide to prevent immune-mediated demyelination. Progress in MS Research Conference, Sydney Australia, 11-13 October 2017. London, United Kingdom: Sage Publications.
2016
Journal Article
A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis
Lund, Maria E., Greer, Judith M., Dixit, Aakanksha, Alvarado, Raquel, McCauley-Winter, Padraig, To, Joyce, Tanaka, Akane, Hutchinson, Andrew T., Robinson, Mark W., Simpson, Ann M., O'Brien, Bronwyn A., Dalton, John P. and Donnelly, Sheila (2016). A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis. Scientific Reports, 6 (1) 37789, 37789. doi: 10.1038/srep37789
2016
Conference Publication
Protection against development of a mouse model of multiple sclerosis by a parasite-derived 68-mer peptide
Dixit, A., Donnelly, S., Lund, M. A., Dalton, J. P. and Greer, J. M. (2016). Protection against development of a mouse model of multiple sclerosis by a parasite-derived 68-mer peptide. ICI 2016 International Congress of Immunology, Melbourne, Australia, 21–26 August 2016. Weinheim, Germany: Wiley. doi: 10.1002/eji.201670200
2013
Journal Article
Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis
Ji, Niannian, Somanaboeina, Animesh, Dixit, Aakanksha, Kawamura, Kazuyuki, Hayward, Neil J., Self, Christopher, Olson, Gary L. and Forsthuber, Thomas G. (2013). Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis. Journal of Immunology, 191 (10), 5074-5084. doi: 10.4049/jimmunol.1300407
2011
Journal Article
Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift
Cantor, Jason R., Yoo, Tae Hyeon, Dixit, Aakanksha, Iverson, Brent L., Forsthuber, Thomas G. and Georgiou, George (2011). Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift. Proceedings of the National Academy of Sciences of the United States of America, 108 (4), 1272-1277. doi: 10.1073/pnas.1014739108
Supervision
Availability
- Dr Aakanksha Dixit is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
A novel humanized mouse model for multiple sclerosis
Associate Advisor
Other advisors: Dr Jun Yan, Associate Professor Judith Greer
Media
Enquiries
For media enquiries about Dr Aakanksha Dixit's areas of expertise, story ideas and help finding experts, contact our Media team: